Holen Sie sich die Stockscreener-App
3.39
8.13%
-0.30
Handel nachbörslich:
3.39
Schlusskurs vom Vortag:
$3.69
Offen:
$3.72
24-Stunden-Volumen:
1.42M
Relative Volume:
0.98
Marktkapitalisierung:
$298.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-2.5682
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
-9.12%
1M Leistung:
-22.43%
6M Leistung:
-53.11%
1J Leistung:
-53.63%
1-Tages-Spanne:
$3.3105
$3.77
1-Wochen-Bereich:
$3.3105
$3.98
52-Wochen-Spanne:
$3.3105
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
3.39 | 298.98M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Mizuho | Buy |
| 2023-06-07 | Eingeleitet | Jefferies | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
Terns Pharmaceuticals stock hits 52-week low at $3.54 - Investing.com India
Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Target Price at $18.30 - Defense World
William Blair Initiates Coverage on Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
William Blair Initiates Terns Pharmaceuticals at Market Perform -February 28, 2025 at 08:12 am EST - Marketscreener.com
William Blair Initiates Coverage of Terns Pharmaceuticals (TERN) with Market Perform Recommendation - MSN
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewswire
Terns Pharmaceuticals reports progress in clinical trials By Investing.com - Investing.com Australia
New Terns Pharmaceuticals CFO Receives $2.8M Stock Option Package: What's Behind the Compensation? - StockTitan
Terns Pharmaceuticals reports progress in clinical trials - Investing.com India
Terns Pharmaceuticals Provides Program Updates and - GlobeNewswire
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th ... - The Bakersfield Californian
Can Terns Pharmaceuticals' $372M Cash Runway Fuel Its Promising CML and Obesity Pipeline? - StockTitan
Terns Pharmaceuticals Names Andrew Gengos as Chief Financial Officer -February 25, 2025 at 04:55 am EST - Marketscreener.com
Its CEO died. The company scrapped a promising program. Now, for their 2nd act. - PharmaVoice
Terns Pharmaceuticals appoints Andrew Gengos as CFO - TipRanks
Terns Pharmaceuticals Appoints Andrew Gengos as CFO - MSN
Terns Pharmaceuticals appoints new CFO to bolster growth By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals appoints new CFO to bolster growth - Investing.com India
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer - The Manila Times
Can This Former Amgen VP Transform Terns Pharmaceuticals as New CFO? - StockTitan
Terns Pharmaceuticals stock hits 52-week low at $4 - Investing.com India
Terns Pharmaceuticals stock hits 52-week low at $4 By Investing.com - Investing.com Nigeria
Oppenheimer Initiates Coverage of Terns Pharmaceuticals (TERN) with Outperform Recommendation - MSN
Terns Pharmaceuticals Appoints Robert Azelby to Board - TipRanks
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors - GlobeNewswire
Can This New Board Addition Transform Terns' Oncology Commercialization Strategy? - StockTitan
Savant Capital LLC Makes New $89,000 Investment in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN
Terns Pharmaceuticals stock hits 52-week low at $4.16 By Investing.com - Investing.com Canada
Bleakley Financial Group LLC Boosts Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals announces CFO transition and consulting agreement - MSN
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - US Post News
Terns Pharma: I Don't See The Positioning (NASDAQ:TERN) - Seeking Alpha
Terns Pharmaceuticals Inc [TERN] stock for 11,498 USD was acquired by Jung Melita Sun - Knox Daily
Autolus Therapeutics plc ADR [AUTL] Officer makes an insider purchase of 698,741 shares worth 2.96 million. - Knox Daily
LIPO Stock Sees Surge of Approximately 74.16% in Last Five Days - Knox Daily
Quoin Pharmaceuticals Ltd ADR [QNRX] stock for 250,000 USD was acquired by Carter Denise P. - Knox Daily
Sage Therapeutics Inc [SAGE] Records 50-Day SMA of $6.17 - Knox Daily
60 Degrees Pharmaceuticals Inc [SXTP] Records 200-Day SMA of $1.8142 - Knox Daily
PTC Therapeutics Inc [PTCT] Records 200-Day SMA of $38.09 - Knox Daily
EyePoint Pharmaceuticals Inc [EYPT] Shares Fall Approximately -76.18% Over the Year - Knox Daily
Travere Therapeutics Inc [TVTX] Records 50-Day SMA of $18.85 - Knox Daily
Lexicon Pharmaceuticals Inc [LXRX] Records 50-Day SMA of $0.7840 - Knox Daily
C4 Therapeutics Inc [CCCC] Records 200-Day SMA of $5.28 - Knox Daily
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by E. Ohman J or Asset Management AB - Armenian Reporter
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.45%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):